Physician

Mohannad Naheid I Abu Omar, M.D

According to 2025 Medicare claims, Mohannad Omar, M.D (NPI: 1598011694) practices pulmonary disease in the St. Joseph, MO-KS market, with the plurality of this provider's patient population coming from Buchanan, MO. This provider's primary affiliated billing organization is HEARTLAND REGIONAL MEDICAL CENTER (NPI: 1538200357; TIN: 440545289) and primary practice location at 64506-3488.

Omar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 743 traditional Medicare patients, billed 2,638 HCPCS/CPT codes, and received $154,908 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,592 prescription claims across 338 beneficiaries totaling $910,629 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,331 claims. Open Payments data shows 16 records totaling $721. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $23,640 to $910,629. For DME billing, reported payments moved sharply higher in recent years, from $879 to $92,398.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	216	751	$54,277
2019	637	2,784	$202,142
2020	697	3,023	$218,509
2021	724	2,803	$192,387
2022	669	2,262	$145,357
2023	739	2,534	$169,462
2024	743	2,638	$154,908

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	282	$23,640
2016	41	205	$37,287
2017	22	110	$21,231
2018	43	100	$21,558
2019	136	411	$101,747
2020	161	698	$226,087
2021	214	1,128	$686,827
2022	256	1,172	$586,484
2023	286	1,345	$714,484
2024	338	1,592	$910,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	22	$830
2018	N/R	29	$1,404
2019	37	433	$23,745
2020	99	693	$58,462
2021	149	889	$74,969
2022	152	967	$86,933
2023	209	1,125	$102,488
2024	256	1,331	$110,164

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	367	564	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	232	740	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	150	160	$12
94726	Test to determine lung volumes using sensors	150	154	$8
94729	Test to examine how well the lungs exchange gases	146	150	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	106	6,780	$141,487
Xolair	Omalizumab	46	1,288	$121,987
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	109	4,650	$72,818
Dupixent Pen	Dupilumab	12	378	$59,532
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	48	3,660	$58,306

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	49	$46,183
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	36	256	$21,827
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,089
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	16	73	$5,745
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	19	85	$4,459

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$721	Pulmonx Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohannad Naheid I. Abu Omar, M.D?

Tedicare shows public-source Medicare data for Mohannad Naheid I. Abu Omar, M.D (NPI 1598011694), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohannad Naheid I. Abu Omar, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohannad Naheid I. Abu Omar, M.D?

Mohannad Naheid I. Abu Omar, M.D is linked to HEARTLAND REGIONAL MEDICAL CENTER (billing NPI 1538200357) in the available physician profile data.

Does Mohannad Naheid I. Abu Omar, M.D have Open Payments data?

Mohannad Naheid I. Abu Omar, M.D has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.